\(
\def\WIPO{World Intellectual Property Organisation}
\)
Embryonic stem cell patents : European law and ethics / edited by Aurora Plomer and Paul Torremans.
2009
G 252 PLO.E
Available at WIPO Library
Items
Details
Title
Embryonic stem cell patents : European law and ethics / edited by Aurora Plomer and Paul Torremans.
Description
xlv, 433 pages ; 25 cm
ISBN
9780199543465
0199543461 hardback
0199543461 hardback
Alternate Call Number
G 252 PLO.E
Summary
A comprehensive interdisciplinary analysis of the EU patent system as applied to biotechnological inventions, this text also considers the legal and ethical controversies arising from overlapping law regimes in the morally fragmented and contested field of human embryonic stem cell related technology.
Bibliography, etc. Note
Includes bibliographical references and index.
Formatted Contents Note
1. The drafting history of the European biotechnology directive;
2. Towards commonality? policy approaches to human embryonic stem cell research in Europe;
3. Human embryonic stem cell research in Central and Eastern Europe: a comparative analysis of regulatory and policy approaches;
4. Morality provisions in law concerning the commercialization of human embryos and stem cells;
5. A comparative analysis of the national implementation of the directive's morality clause;
6. The construction of the directive's moral exclusions under the EPC;
7. Towards systemic legal conflict: article 6(2) (c) of the EU directive on biotechnological inventions;
8. Human dignity, human rights, and article 6(1) of the EU directive on biotechnological inventions;
9. Institutional and jurisdictional aspects of stem cell patenting in Europe (EC and EPO): tensions and prospects;
10. A transnational institution confronted with a single jurisdiction model: guidance for the EPO's implementation of the directive from a private international law perspective;
11. An ethics committee for patent offices?
12. The research exemption in patent law and its application to hESC research;
13. Human embryos, patents, and global trade: assessing the scope and contents of the TRIPS morality exception;
14. Stem cells patenting and competition law.
2. Towards commonality? policy approaches to human embryonic stem cell research in Europe;
3. Human embryonic stem cell research in Central and Eastern Europe: a comparative analysis of regulatory and policy approaches;
4. Morality provisions in law concerning the commercialization of human embryos and stem cells;
5. A comparative analysis of the national implementation of the directive's morality clause;
6. The construction of the directive's moral exclusions under the EPC;
7. Towards systemic legal conflict: article 6(2) (c) of the EU directive on biotechnological inventions;
8. Human dignity, human rights, and article 6(1) of the EU directive on biotechnological inventions;
9. Institutional and jurisdictional aspects of stem cell patenting in Europe (EC and EPO): tensions and prospects;
10. A transnational institution confronted with a single jurisdiction model: guidance for the EPO's implementation of the directive from a private international law perspective;
11. An ethics committee for patent offices?
12. The research exemption in patent law and its application to hESC research;
13. Human embryos, patents, and global trade: assessing the scope and contents of the TRIPS morality exception;
14. Stem cells patenting and competition law.
Location
Z01
Published
Oxford : Oxford University Press, c2009.
Language
English
Record Appears in
all